Fax: (011) 86-731-85533525
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo
Article first published online: 28 JUN 2011
DOI: 10.1002/cncr.26251
Copyright © 2011 American Cancer Society
Additional Information
How to Cite
Fang, F., Yang, L., Tao, Y. and Qin, W. (2012), FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Cancer, 118: 134–146. doi: 10.1002/cncr.26251
- †
Fax: (011) 86-731-85533525
Publication History
- Issue published online: 16 DEC 2011
- Article first published online: 28 JUN 2011
- Manuscript Accepted: 15 APR 2011
- Manuscript Revised: 14 APR 2011
- Manuscript Received: 29 SEP 2010
REFERENCES
- 1, , , . Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004; 127: S5-S16.
- 2, , , . Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
- 3. Sorafenib in liver cancer—just the beginning. N Engl J Med. 2008; 359: 420-422.
- 4, , , , , . Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009; 249: 118-123.
- 5, , , et al. Biology of hepatocellular carcinoma. Ann Surg Oncol. 2008; 15: 962-971.
- 6, , , et al. Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study. J Gastrointest Surg. 2008; 12: 327-337.
- 7
- 8, , . Epidemiology of primary liver cancer. Semin Liver Dis. 1999; 19: 271-285.
- 9, , , et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer. 2000; 85: 498-502.
- 10, , , , , . Genetic mechanisms of hepatocarcinogenesis. Oncogene. 2002; 21: 2593-2604.
- 11, , , , , . Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology. 1999; 29: 1858-1862.
- 12, , , , , . Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology. 2009; 50: 1839-1850.
- 13, , , . molecular pathogenesis of hepatocellular carcinoma. J Surg Res. 2006; 136: 125-135.
- 14, , , . Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Cancer Res. 2001; 61: 2085-2091.
- 15, , . Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol. 1997; 17: 3786-3798.
- 16, . Fold prediction and evolutionary analysis of the POZ domain: structural and evolutionary relationship with the potassium channel tetramerization domain. J Mol Biol. 1999; 285: 1353-1361.
- 17, , , , , . FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res. 1999; 27: 1251-1262.
- 18, , , et al. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p 53 and Sp1. J Biol Chem. 2009; 284: 12633-12644.
- 19, , , et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature. 2005; 433: 278-285.
- 20, , , et al. FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB. J Biol Chem. 2005; 280: 27783-27791.
- 21, , , , , . Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem. 2008; 283: 33199-33210.
- 22, , , et al. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol. 2007; 213: 294-302.
- 23
- 24, , , et al. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers. Exp Mol Pathol. 2010; 89: 140-148.
- 25, , , , . p 53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection. Cancer. 2009; 115: 4554-4563.
- 26, , , , , . Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2006; 12: 5673-5679.
- 27, , , , . Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo. Clin Cancer Res. 2008; 14: 6804-6812.
- 28, , , . The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by up-regulation of matrix metalloproteinases. Int J Cancer. 2007; 120: 1208-1214.
- 29, , , et al. CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest. 2010; 120: 3326-3339.
- 30, , . AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma. Mol Cancer Ther. 2007; 6: 2468-2476.
- 31, , , et al. Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg. 2006; 192: 29-33.
- 32, , , et al. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma-results of 152 resected cases. Hepatogastroenterology. 2007; 54: 2084-2087.
- 33, , , et al. p27(Kip1)is overexpressed in very early stages of hepatocarcinogenesis. Cancer Sci. 2008; 99: 2152-2159.
- 34, , . Cell cycle regulators and human hepatocarcinogenesis. Hepatogastroenterology. 1998; 45: 1635-1642.
- 35, . Live or let die: the cell's response to p53. Nat Rev Cancer. 2002; 2: 594-604.
- 36, . Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer. 2006; 6: 909-923.
- 37, , , , , . P53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res. 1994; 54: 231-235.
- 38, , , . Curcumin decreases the expression of Pokemon by suppressing the binding activity of the Sp1 protein in human lung cancer cells. Mol Biol Rep. 2010; 37: 1627-1632.